Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meike Kasten

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Parkinsonism & Related Disorders|January 22, 2014
Non-motor phenotype of dopa-responsive dystonia and quality of life assessmentNorbert Brüggemann, Sophie Stiller, Vera Tadic, et al.
Neurology|September 19, 2019
Risky behaviors and Parkinson disease: A mendelian randomization studySandeep Grover, Christina M Lill, Meike Kasten, et al.
Journal of Parkinson'S Disease|February 18, 2022
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson's DiseaseJannik Prasuhn, Robert Strautz, Felicitas Lemmer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2018
Neuroimaging abnormalities in individuals exhibiting Parkinson's disease risk markersMarcus Heldmann, Janna Heeren, Christine Klein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 3, 2020
Age at Onset of LRRK2 p.Gly2019Ser Is Related to Environmental and Lifestyle FactorsTheresa Lüth, Inke R König, Anne Grünewald, et al.
Behavioural Neurology|September 10, 2015
Qualitative Characteristics of Depression in Parkinson's Patients and ControlsCleo Kritzinger, Eva-Juliane Vollstedt, Katja Hückelheim, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2020
The Impact of COVID-19 on Access to Parkinson's Disease MedicationJulia Ling-Yu Cheong, Zhao Hang Keith Goh, Connie Marras, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2022
Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson's diseaseJannik Prasuhn, Martin Göttlich, Friederike Gerkan, et al.
Frontiers in Neurology|January 11, 2020
The Role of Rare Coding Variants in Parkinson's Disease GWAS LociElisabeth Luisa Germer, Sophie Imhoff, Carles Vilariño-Güell, et al.
Frontiers in Neurology|January 28, 2021
The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group DesignJannik Prasuhn, Meike Kasten, Melissa Vos, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Parkinsonism & Related Disorders|January 22, 2014
Non-motor phenotype of dopa-responsive dystonia and quality of life assessmentNorbert Brüggemann, Sophie Stiller, Vera Tadic, et al.
Neurology|September 19, 2019
Risky behaviors and Parkinson disease: A mendelian randomization studySandeep Grover, Christina M Lill, Meike Kasten, et al.
Journal of Parkinson'S Disease|February 18, 2022
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson's DiseaseJannik Prasuhn, Robert Strautz, Felicitas Lemmer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2018
Neuroimaging abnormalities in individuals exhibiting Parkinson's disease risk markersMarcus Heldmann, Janna Heeren, Christine Klein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 3, 2020
Age at Onset of LRRK2 p.Gly2019Ser Is Related to Environmental and Lifestyle FactorsTheresa Lüth, Inke R König, Anne Grünewald, et al.
Behavioural Neurology|September 10, 2015
Qualitative Characteristics of Depression in Parkinson's Patients and ControlsCleo Kritzinger, Eva-Juliane Vollstedt, Katja Hückelheim, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2020
The Impact of COVID-19 on Access to Parkinson's Disease MedicationJulia Ling-Yu Cheong, Zhao Hang Keith Goh, Connie Marras, et al.
Molecular Medicine (Cambridge, Mass.)|March 5, 2022
Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson's diseaseJannik Prasuhn, Martin Göttlich, Friederike Gerkan, et al.
Frontiers in Neurology|January 11, 2020
The Role of Rare Coding Variants in Parkinson's Disease GWAS LociElisabeth Luisa Germer, Sophie Imhoff, Carles Vilariño-Güell, et al.
Frontiers in Neurology|January 28, 2021
The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group DesignJannik Prasuhn, Meike Kasten, Melissa Vos, et al.
Pageof 10